Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04941443 · ClinicalTrials.gov registry record · Phase 4
Methadone and Medication Abortion
A Phase 4 study, sponsored by Boston Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT04941443 is a Phase 4 study that was terminated before completion, run by Boston Medical Center. The registered enrollment target is 4 participants.
The verdict
NCT04941443, a Phase 4 study, was terminated before completion, sponsored by Boston Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
Pain has been recognized to be the most common and predictable side effect of medication abortion, causing significant distress associated with the process. Yet there is little known about the appropriate management of pain during this process, with no current evidence based recommendations for optimal analgesic regimens during the first trimester. The goal of this study is to evaluate the efficacy of oral methadone for pain control during medication abortion. The current medication regimen used to perform medication abortion is a dose of mifepristone (antiprogesterone) orally, followed by a dose of misoprostol (prostaglandin analogue) 24 to 72 hours later. Patients are prescribed a standard dose of ibuprofen 600-800mg tabs for pain control during the process. The investigators will conduct a non-randomized, pilot study with 25 patients evaluated at the Boston Medical Center family planning clinic at 10 weeks of gestation or less for medication abortion.
Interventions
- DRUG Ibuprofen
- DRUG Methadone Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-10-04 |
| Est. Completion | 2022-03-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04941443
The ClinicalTrials.gov registry entry for NCT04941443 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen is the first listed.
NCT04941443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04941443 about?
NCT04941443 is a clinical study titled "Methadone and Medication Abortion". Pain has been recognized to be the most common and predictable side effect of medication abortion, causing significant distress associated with the process. Yet there is little known about the appropriate management of pain during this process, with no current evidence based recommendations for opti...
What is the current status of trial NCT04941443?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2021-10-04. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT04941443?
The interventions under investigation include: Ibuprofen (DRUG), Methadone Pill (DRUG).
Who is sponsoring clinical trial NCT04941443?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.